
|Videos|April 22, 2019
High-Risk IgVH-Unmutated Chronic Lymphocytic Leukemia
High-Risk IgVH-Unmutated Chronic Lymphocytic Leukemia
Advertisement
Case:A 62-YearOld Male WithIgVH-Unmutated CLL
- A 62-year-old male presented to PCP with complaints of extreme fatigue and night sweats
- PE: Enlarged mobile lymph nodes bilaterally (~1.5 cm), no palpable spleen or liver
- Laboratory findings:
- WBC; 100 X 109/L
- Lymphocytes; 82 X 109/L
- Hb; 11.2 g/dL
- Platelets; 190 X 109/L
- ANC; 1,950/mm3
- LDH 150 U/L
- Cytogenetic; del(11q),IgVH-unmutated
- β2M, 2.9 mg/L
- Referred to community oncology who diagnosed patient with chronic lymphocytic leukemia
- Patient was started on ibrutinib + rituximab (IR)
- Rai Stage I
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































